+5,430.8%
TTWO vs GSK
+378.0%
+5,052.8%
-80.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +6.2% | -1.3% | +7.6% | +6.6% |
| 7D | -6.4% | -3.1% | -3.2% | -5.5% |
| 30D | +5.7% | -0.9% | +6.6% | +5.9% |
| 3M | -10.6% | -4.2% | -6.5% | -9.7% |
| 6M | -10.6% | -1.6% | -9.0% | -10.5% |
| YTD | -15.4% | +2.6% | -18.0% | -17.2% |
| 1Y | -9.4% | +6.2% | -15.6% | -12.3% |
| 3Y | +40.3% | +55.0% | -14.7% | +18.0% |
| 5Y | +24.5% | +42.8% | -18.3% | +5.4% |
| 10Y | +354.7% | +102.1% | +252.6% | +236.6% |
| All | +5,430.8% | +378.0% | +5,052.8% | +3,122.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling